A new drug targeting a rare kind of lung cancer could give patients two extra years of life after NHS drug watchdogs approving it for use. About 100 patients in England will benefit per year.
from Home | Mail Online https://ift.tt/YTlPWEI
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Thanks For Comment We will Contact You With In 24 Hours